Corrigendum to: 'A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry' and articles listed below
- PMID: 36799232
- PMCID: PMC10117570
- DOI: 10.1002/ejhf.2789
Corrigendum to: 'A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry' and articles listed below
Erratum for
-
Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction.Eur J Heart Fail. 2022 Mar;24(3):431-441. doi: 10.1002/ejhf.2397. Epub 2022 Jan 17. Eur J Heart Fail. 2022. PMID: 34894038 Free PMC article. Review.
-
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry.Eur J Heart Fail. 2022 Feb;24(2):335-350. doi: 10.1002/ejhf.2408. Epub 2022 Jan 10. Eur J Heart Fail. 2022. PMID: 34962044
-
Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2022 Feb;24(2):249-253. doi: 10.1002/ejhf.2430. Epub 2022 Jan 23. Eur J Heart Fail. 2022. PMID: 35014132 No abstract available.
-
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.Eur J Heart Fail. 2022 May;24(5):821-832. doi: 10.1002/ejhf.2478. Epub 2022 Mar 29. Eur J Heart Fail. 2022. PMID: 35279929 Free PMC article.
-
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2022 Jun;24(6):927-943. doi: 10.1002/ejhf.2493. Epub 2022 Apr 21. Eur J Heart Fail. 2022. PMID: 35334137 Review.
-
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2022 Jun;24(6):944-958. doi: 10.1002/ejhf.2522. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35488811 Review.
-
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2022 Jul;24(7):1162-1170. doi: 10.1002/ejhf.2575. Epub 2022 Jul 5. Eur J Heart Fail. 2022. PMID: 35703329
-
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.Eur J Heart Fail. 2022 Oct;24(10):1751-1766. doi: 10.1002/ejhf.2664. Epub 2022 Sep 7. Eur J Heart Fail. 2022. PMID: 36039656 Review.
-
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.Eur J Heart Fail. 2022 Nov;24(11):2000-2018. doi: 10.1002/ejhf.2669. Epub 2022 Oct 6. Eur J Heart Fail. 2022. PMID: 36065751 Free PMC article. Review.
-
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2022 Oct;24(10):1767-1777. doi: 10.1002/ejhf.2675. Epub 2022 Sep 20. Eur J Heart Fail. 2022. PMID: 36073112 Review.
References
-
- Kapłon‐Cieślicka A, Benson L, Chioncel O, Crespo‐Leiro MG, Coats AJS, Anker SD, et al.; Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long‐Term Registry Investigators. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry. Eur J Heart Fail. 2022;24:335–50. - PubMed
-
- Seferović P, Farmakis D, Bayes‐Genis A, Ben Gal T, Böhm M, Chioncel O, et al. Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022;24:1162–70. - PubMed
-
- Bayes‐Genis A, Aimo A, Jhund P, Richards M, de Boer RA, Arfsten H, et al. Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022;24:1767–77. - PubMed
-
- González A, Richards AM, de Boer RA, Thum T, Arfsten H, Hülsmann M, et al. Cardiac remodelling – part 1: from cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022;24:927–43. - PubMed
-
- Aimo A, Vergaro G, González A, Barison A, Lupón J, Delgado V, et al. Cardiac remodelling – part 2: clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022;24:944–58. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
